Alzheimer's-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions

Area of Science:

• Molecular Biology
• Neuroscience
• Biochemistry

Background:

• Alzheimer's disease (AD) is linked to mutations in Presenilins (PSEN) and amyloid precursor protein (APP).
• These mutations alter amyloid-beta (Aβ) peptide length, a key factor in AD pathogenesis.
• The precise mechanism driving this shift in Aβ length remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which PSEN and APP mutations influence Aβ peptide length.
• To investigate the role of enzyme-substrate complex stability in γ-secretase processing.
• To identify potential therapeutic targets for preventing AD.

Main Methods:

• Investigated the stability of enzyme-substrate (E-S) complexes during sequential γ-secretase processing of APP.
• Utilized pathogenic PSEN and APP mutations to assess their impact on E-S complex stability.
• Examined the effects of environmental factors (temperature, compounds, detergent) and stabilizers on Aβ production and E-S complex stability.

Main Results:

• Substrate shortening progressively destabilizes E-S complexes during APP processing by γ-secretase.
• Pathogenic PSEN or APP mutations further destabilize these complexes, promoting longer Aβ peptide generation.
• Destabilization of E-S complexes by various factors increases amyloidogenic Aβ release, while stabilizers enhance γ-secretase processivity.

Conclusions:

• Presents a unifying model where PSEN/APP mutations and environmental factors destabilize E-S complexes, enhancing amyloidogenic Aβ production.
• Suggests that environmental factors may contribute to AD risk.
• Provides a theoretical foundation for developing γ-secretase/substrate stabilizing compounds to prevent AD.